Literature DB >> 18332812

Differences in early- and late-onset ventilator-associated pneumonia between surgical and trauma patients in a combined surgical or trauma intensive care unit.

Traci L Hedrick1, Robert L Smith, Shannon T McElearney, Heather L Evans, Philip W Smith, Timothy L Pruett, Jeffrey S Young, Robert G Sawyer.   

Abstract

INTRODUCTION: Ventilator-associated pneumonia (VAP) is a leading cause of morbidity in the perioperative period. Based on differences in causes, VAP has been divided into early (</=96 hours of admission) and late (>96 hours of admission) onset. We sought to compare differences in patient characteristics and outcome between early- and late-onset VAP in trauma and nontrauma surgical patients.
METHODS: A retrospective analysis of prospectively collected data were performed for all surgical and trauma patients admitted to the surgical or trauma intensive care unit of an academic medical center from December 1996 to March 2005 who developed VAP. Patients with early- and late-onset VAP were compared with regard to patient characteristics, cause, and outcome using bivariate and multivariate analyses.
RESULTS: Three hundred thirty VAPs were identified in 233 trauma (71%) and 97 nontrauma surgery patients (29%). There was no statistically significant difference in recurrence, mortality, or length of stay between early- and late-onset VAP in trauma patients. Mortality for late- onset VAPs in nontrauma patients was 44% versus 23% for early-onset VAPs (p = 0.09). On a per case basis, trauma patients had significantly better mortality (11% vs. 41%) and length of stay (33.1 +/- 1.4 vs. 55.8 +/- 4.1 days) than nontrauma surgical patients with VAP (p < 0.0001), although the rate of VAP-related death favored the nontrauma patients (1.8 deaths of 100 intensive care unit trauma admissions vs. 1.1 deaths of 100 intensive care unit nontrauma admissions, p = 0.05).
CONCLUSIONS: Although there is a trend toward worse outcome in nontrauma patients with late-onset VAP, trauma patients with late- and early-onset VAP behave similarly. On a per case basis, trauma patients have significantly better outcomes than nontrauma surgical patients with VAP when cared for within the same surgical or trauma intensive care unit.

Entities:  

Mesh:

Year:  2008        PMID: 18332812     DOI: 10.1097/TA.0b013e31811ec18e

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  7 in total

1.  Mechanical ventilator as a major cause of infection and drug resistance in intensive care unit.

Authors:  Marwa M E Abd-Elmonsef; Dalia Elsharawy; Ayman S Abd-Elsalam
Journal:  Environ Sci Pollut Res Int       Date:  2017-02-23       Impact factor: 4.223

2.  Trimetoprim-sulfametoxazole in ventilator-associated pneumonia: a cohort study.

Authors:  Alessio Strazzulla; Maria Concetta Postorino; Anastasia Purcarea; Catherine Chakvetadze; Astrid de Farcy de Pontfarcy; Gianpiero Tebano; Aurelia Pitsch; Lyvan Vong; Sebastien Jochmans; Christophe Vinsonneau; Mehran Monchi; Sylvain Diamantis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-08-01       Impact factor: 3.267

3.  Early- and late-onset pneumonia: is this still a useful classification?

Authors:  Petra Gastmeier; Dorit Sohr; Christine Geffers; Henning Rüden; Ralf-Peter Vonberg; Tobias Welte
Journal:  Antimicrob Agents Chemother       Date:  2009-04-13       Impact factor: 5.191

4.  A comparison of diagnostic algorithms and clinical parameters to diagnose ventilator-associated pneumonia: a prospective observational study.

Authors:  Farshid Rahimibashar; Andrew C Miller; Mojtaba H Yaghoobi; Amir Vahedian-Azimi
Journal:  BMC Pulm Med       Date:  2021-05-13       Impact factor: 3.317

5.  Extrathoracic multiple trauma dysregulates neutrophil function and exacerbates pneumonia-induced lung injury.

Authors:  Jennifer M Leonard; Christina X Zhang; Liang Lu; Mark H Hoofnagle; Anja Fuchs; Regina A Clemens; Sarbani Ghosh; Shin-Wen Hughes; Grant V Bochicchio; Richard Hotchkiss; Isaiah R Turnbull
Journal:  J Trauma Acute Care Surg       Date:  2021-06-01       Impact factor: 3.697

6.  Developing a gene expression model for predicting ventilator-associated pneumonia in trauma patients: a pilot study.

Authors:  Joseph M Swanson; G Christopher Wood; Lijing Xu; Lisa E Tang; Bernd Meibohm; Ramin Homayouni; Martin A Croce; Timothy C Fabian
Journal:  PLoS One       Date:  2012-08-15       Impact factor: 3.240

7.  Trimethoprim-sulfamethoxazole as de-escalation in ventilator-associated pneumonia: a cohort study subanalysis.

Authors:  Alessio Strazzulla; Maria Concetta Postorino; Tracie Youbong; Maxence Rouyer; Clara Flateau; Catherine Chakvetadze; Astrid de Pontfarcy; Aurelia Pitsch; Sebastien Jochmans; Nabil Belfeki; Mehran Monchi; Sylvain Diamantis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-02-24       Impact factor: 3.267

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.